Literature DB >> 810508

Depression of cell-mediated immunity in atopic eczema.

S J McGeady, R H Buckley.   

Abstract

Prompted by recent observations that the thymus exerts an important regulatory influence over IgE antibody production in lower species, we conducted studies of immune function in 21 patients with atopic eczema to seek evidence for a similar relation in man. Skin tests for delayed hypersensitivity to Candida albicans and streptokinase-streptodornase (SK-SD) revealed a striking degree of anergy that correlated with the severity of the eczema. A correlation was also noted between the extent of the dermatitis and the magnitude of the serum IgE concentration. Other immunologic abnormalities did not appear related to the severity of eczema put pertained to the group as a whole. These included significantly (p = less than 0.0001) lower mean percentages of spontaneous sheep erythrocyte (E) or T cell rosettes and of rosettes with neuraminidase-treated sheep erythrocyte (En) rosettes, and significantly lower in vitro lymphocyte responsiveness of the mitogens concanavalin A (p = 0.0013) and poleweek mitogen (p = 0.0002) and to Candida antigen (p = 0.0017) than in normal subjects. Responses to phytohemagglutinin and tetanus toxoid were also depressed but differences were not statistically significant. An increased percentage (p = 0.0324) of peripheral blood B lymphocytes bearing the complement receptor was noted, but, except for a slight increase in lymphocytes bearing IgD, percentages of lymphocytes bearing other immunoglobulins (including IgE) were not elevated.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 810508     DOI: 10.1016/0091-6749(75)90133-5

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  26 in total

1.  Lymphocyte suppressor activity in atopic eczema.

Authors:  B E Ogden; G G Krueger; H R Hill
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

Review 2.  Clinical significance of anti-IgE autoantibodies and immune complexes containing IgE.

Authors:  C G Magnusson; S G Johansson
Journal:  Clin Rev Allergy       Date:  1989

Review 3.  Evaluation of in vitro IgE testing to diagnose atopic diseases.

Authors:  G M Halpern
Journal:  Clin Rev Allergy       Date:  1989

4.  Decreased expression of filaggrin in atopic skin.

Authors:  T Seguchi; C Y Cui; S Kusuda; M Takahashi; K Aisu; T Tezuka
Journal:  Arch Dermatol Res       Date:  1996-07       Impact factor: 3.017

5.  T-cell function in atopic dermatitis. Controlled examination of concanavalin A dose-response relations in cultured lymphocytes.

Authors:  E Schöpf; A Kapp; C W Kim
Journal:  Arch Dermatol Res       Date:  1978-06-29       Impact factor: 3.017

6.  Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis.

Authors:  T Jakob; B N Huspith; Y E Latchman; R Rycroft; J Brostoff
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

7.  Decreased monocyte production of interleukin-1 and impaired lymphocyte proliferation in atopic dermatitis.

Authors:  L Räsänen; M Lehto; T Reunala; C Jansen; P Leinikki
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

8.  Restoration by levamisole of low E-rosette forming cells in patients suffering from various diseases.

Authors:  H Verhaegen; J De Cree; W De Cock; F Verbruggen
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

9.  Role of T gamma cells in the in vitro IgE response after antigenic stimulation.

Authors:  C Vela; R Garcia; L Tricas; C Platas; C Lahoz
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

10.  Histamine regulates lymphocyte mitogenic responses through activation of specific H1 and H2 histamine receptors.

Authors:  B E Ogden; H R Hill
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.